10x Genomics, Inc. (NASDAQ:TXG) Q2 2025 Earnings Call Transcript
Operator: Hello, and thank you for standing by. My name is Tiffany, and I will be your conference operator today.
10X Genomics Inc. (TXG)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | ARK Investment Management Catherine D. Wood | 13,892,103 | $160,870,554 | +9% | 1.18% |
| 2. | AQR Capital Management Cliff Asness | 4,137,801 | $47,915,736 | +242% | 0.04% |
| 3. | Millennium Management Israel Englander | 2,883,827 | $33,394,717 | -47% | 0.02% |
| 4. | Quantinno Capital Hoon Kim | 2,233,526 | $25,864,231 | +208% | 0.11% |
| 5. | Two Sigma Advisors John Overdeck And David Siegel | 1,814,600 | $21,013,068 | +5% | 0.04% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $11.14 | 40,000 | $445,572.00 | 61,691 | 2025-02-21 | Filing | |
| $40.49 | 158 | $6,396.71 | 60,046 | 2022-05-13 | Filing | |
| $40.49 | 158 | $6,396.71 | 97,523 | 2022-05-13 | Filing | |
| $39.00 | 300,000 | $11,700,000.00 | 300,000 | 2019-09-16 | Filing | |
| $39.00 | 300,000 | $11,700,000.00 | 300,000 | 2019-09-16 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.79 | 9,348 | $128,880.88 | 945,892 | 2025-08-22 | Filing | |
| $13.79 | 22,315 | $307,656.91 | 309,273 | 2025-08-22 | Filing | |
| $13.79 | 7,486 | $103,209.48 | 440,888 | 2025-08-22 | Filing | |
| $8.30 | 9,343 | $77,540.36 | 1,083,625 | 2025-05-22 | Filing | |
| $8.30 | 7,485 | $62,120.26 | 448,374 | 2025-05-22 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 12,440,060 | $144,055,895 | 0% | |
| 2. | 9,434,496 | $109,251,464 | 0% | |
| 3. | 8,996,404 | $104,178,355 | 0.01% | |
| 4. | 6,017,963 | $69,688,012 | 0.04% | |
| 5. | 6,009,653 | $69,531,685 | 0.69% |
News See All
10x Genomics Settles Patent Dispute With Bruker
10x Genomics, Inc. (NASDAQ:TXG) is among the 11 Best Genomics Stocks to Buy According to Hedge Funds.
11 Best Genomics Stocks to Buy According to Hedge Funds
Genomics is the study of genes and how they operate.
Brown Capital Management Small Company Fund Sold 10x Genomics (TXG) Due to Fundamental Concerns
Brown Capital Management, an investment management company, released its “The Brown Capital Management Small Company Fund” first quarter 2025 investor letter.
10x Genomics, Inc. (NASDAQ:TXG) Q1 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you so much for standing by and welcome to 10x Genomics First Quarter 2025 Earnings Conference Call. Please note that this call is being recorded.
10x Genomics, Inc. (NASDAQ:TXG) Q4 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is [Prilla] and I will be your conference operator today.
Cathie Wood's Stock Portfolio: 2025 Stock Picks
Cathie Wood is one of Wall Street's most contentious figures.
10 Best Genomics Stocks To Buy Right Now
Genomics is the study of genes and how they function.
10x Genomics, Inc. (NASDAQ:TXG) Q3 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Mark, and I will be your conference operator today.
10x Genomics, Inc. (NASDAQ:TXG) Q2 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Kayla and I will be your conference operator today.
Billionaire Hedge Funds
